← Back to Treatments
🏅 FDA Orphan Designation

Rilutek

Riluzole

Manufacturer: Rhone-Poulenc Rorer Pharmaceuticals, Inc.

Indicated for:
Amyotrophic lateral sclerosisOrphan

FDA-Approved Indications (1)

Treatment of patients with amyotrophic lateral sclerosis (ALS). Riluzole extends survival and time to tracheostomy. First drug approved for ALS (1995).

Indications & Usage

Treatment of patients with amyotrophic lateral sclerosis. Riluzole extends survival and/or time to tracheostomy.

💙 Support Programs

View all →
Rilutek
Rhone-Poulenc Rorer Pharmaceuticals, Inc.
Riluzole
Sanofi
Copay card ↗Apply ↗

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.